Treatment of acute urinary tract infection with three doses of co-trimoxazole. 1981

J Rapoport, and G A Rees, and N J Willmott, and R C Slack, and F W O'Grady

UI MeSH Term Description Entries
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000892 Anti-Infective Agents, Urinary Substances capable of killing agents causing urinary tract infections or of preventing them from spreading. Antiseptics, Urinary,Antiinfective Agents, Urinary,Urinary Anti-Infective Agents,Urinary Antiinfective Agents,Agents, Urinary Anti-Infective,Agents, Urinary Antiinfective,Anti Infective Agents, Urinary,Urinary Anti Infective Agents,Urinary Antiseptics
D013420 Sulfamethoxazole A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208) Sulfamethylisoxazole,Gantanol,Sulfisomezole,Sulphamethoxazole
D014295 Trimethoprim A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported. Proloprim,Trimpex
D014552 Urinary Tract Infections Inflammatory responses of the epithelium of the URINARY TRACT to microbial invasions. They are often bacterial infections with associated BACTERIURIA and PYURIA. Infection, Urinary Tract,Infections, Urinary Tract,Tract Infection, Urinary,Tract Infections, Urinary,Urinary Tract Infection
D015662 Trimethoprim, Sulfamethoxazole Drug Combination A drug combination with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. It is effective in the treatment of many infections, including PNEUMOCYSTIS PNEUMONIA in AIDS. Trimethoprim-Sulfamethoxazole Combination,Abactrim,Bactifor,Bactrim,Biseptol,Biseptol-480,Centran,Centrin,Co-Trimoxazole,Cotrimoxazole,Drylin,Eslectin,Eusaprim,Insozalin,Kepinol,Kepinol Forte,Lescot,Metomide,Oriprim,Septra,Septrin,Sulfamethoxazole-Trimethoprim Combination,Sulprim,Sumetrolim,TMP SMX,TMP-SMX,Trimedin,Trimethoprim-Sulfamethoxazole,Trimethoprimsulfa,Trimezole,Trimosulfa,Biseptol 480,Biseptol480,Co Trimoxazole,Sulfamethoxazole Trimethoprim Combination,Trimethoprim Sulfamethoxazole,Trimethoprim Sulfamethoxazole Combination

Related Publications

J Rapoport, and G A Rees, and N J Willmott, and R C Slack, and F W O'Grady
June 1973, The Medical journal of Australia,
J Rapoport, and G A Rees, and N J Willmott, and R C Slack, and F W O'Grady
November 1986, The Journal of antimicrobial chemotherapy,
J Rapoport, and G A Rees, and N J Willmott, and R C Slack, and F W O'Grady
December 1980, Australian and New Zealand journal of medicine,
J Rapoport, and G A Rees, and N J Willmott, and R C Slack, and F W O'Grady
March 1983, The Journal of antimicrobial chemotherapy,
J Rapoport, and G A Rees, and N J Willmott, and R C Slack, and F W O'Grady
May 1976, British medical journal,
J Rapoport, and G A Rees, and N J Willmott, and R C Slack, and F W O'Grady
June 1983, Urology,
J Rapoport, and G A Rees, and N J Willmott, and R C Slack, and F W O'Grady
March 1974, The Medical journal of Malaysia,
J Rapoport, and G A Rees, and N J Willmott, and R C Slack, and F W O'Grady
February 1981, The Journal of antimicrobial chemotherapy,
J Rapoport, and G A Rees, and N J Willmott, and R C Slack, and F W O'Grady
January 1990, BMJ (Clinical research ed.),
J Rapoport, and G A Rees, and N J Willmott, and R C Slack, and F W O'Grady
November 1981, British medical journal (Clinical research ed.),
Copied contents to your clipboard!